共 50 条
- [44] Levoketoconazole improves clinical signs and symptoms and patient-reported outcomes in patients with Cushing’s syndrome Pituitary, 2021, 24 : 104 - 115
- [46] Combination treatment with mirabegron and solifenacin in patients with overactive bladder: exploratory responder analyses of efficacy and evaluation of patient-reported outcomes from a randomized, double-blind, factorial, dose-ranging, Phase II study (SYMPHONY) WORLD JOURNAL OF UROLOGY, 2017, 35 (05) : 827 - 838
- [47] Comparative study of different combinations of mirabegron and antimuscarinics in treatment for overactive bladder syndrome in elderly patients TZU CHI MEDICAL JOURNAL, 2023, 35 (01): : 62 - 68
- [48] Combination treatment with mirabegron and solifenacin in patients with overactive bladder: exploratory responder analyses of efficacy and evaluation of patient-reported outcomes from a randomized, double-blind, factorial, dose-ranging, Phase II study (SYMPHONY) World Journal of Urology, 2017, 35 : 827 - 838
- [49] Golimumab Improves Patient-Reported Outcomes In Patients With Active Rheumatoid Arthritis ARTHRITIS AND RHEUMATISM, 2013, 65 : S209 - S209
- [50] IMPROVED PATIENT-REPORTED OUTCOMES (PROS) WITH MIRABEGRON ADD-ON TREATMENT IN A RANDOMIZED, DOUBLE-BLIND, PHASE 3B STUDY IN INCONTINENT OVERACTIVE BLADDER (OAB) PATIENTS WITH AN INADEQUATE RESPONSE TO SOLIFENACIN JOURNAL OF UROLOGY, 2016, 195 (04): : E849 - E849